Bicycle Therapeutics (BCYC) EBITDA Margin Growth (3y) (2021 - 2026)
Bicycle Therapeutics (BCYC) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -652,859.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -652,859.00 |
| Dec 31, 2025 | 33,194.00 |
| Sep 30, 2025 | 42,027.00 |
| Jun 30, 2025 | -245,073.00 |
| Mar 31, 2025 | 575.00 |
| Dec 31, 2024 | -69,828.00 |
| Sep 30, 2024 | -205,599.00 |
| Jun 30, 2024 | 46,959.00 |
| Mar 31, 2024 | 58,132.00 |
| Dec 31, 2023 | -57,400.00 |
| Sep 30, 2023 | -67,127.00 |
| Jun 30, 2023 | 42,269.00 |
| Mar 31, 2023 | 17,745.00 |
| Dec 31, 2022 | -29,325.00 |
| Sep 30, 2022 | 69,096.00 |
| Jun 30, 2022 | 974.00 |
| Mar 31, 2022 | -65,781.00 |
| Dec 31, 2021 | -41,297.00 |
| Sep 30, 2021 | 6,496.00 |
| Jun 30, 2021 | -66,940.00 |